Cingulate Inc. has entered into a significant agreement with Lincoln Park Capital Fund, LLC, allowing for the purchase of up to $25 million of Cingulate's common stock. Under this arrangement, Cingulate will maintain control over the timing and amount of stock sales to Lincoln Park, which is obligated to purchase shares as directed by the company. The deal is structured to occur over a 36-month period, contingent upon certain conditions, including the effectiveness of a registration statement filed with the SEC. This agreement provides Cingulate with financial flexibility, as there are no upper limits on the price per share that Lincoln Park must pay, and the company can initiate stock sales at its discretion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.